Who owns AYTU BIOPHARMA INC?
- Ticker: AYTU
- CUSIP Number: 054754858
Tip: Access positions for across all investors
Analyze quarterly positions in Aytu Biopharma with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Aytu Biopharma stock
Who bought or sold AYTU BIOPHARMA INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Nantahala Capital Management | 1.1M | $3.0M | 0% | Mar 2026 |
|
| Stonepine Capital Management | 814k | $2.1M | -9% | Dec 2025 |
|
| AWM Investment Company | 620k | $1.7M | 0% | Mar 2026 |
|
| Diadema Partners | 306k | $795k | 12% | Dec 2025 |
|
| Vanguard Group | 279k | $724k | 0% | Dec 2025 |
|
| Vanguard Capital Management | 261k | $713k | 100% | Mar 2026 |
|
| Crown Advisors Management | 145k | $395k | 100% | Mar 2026 |
|
| Two Sigma Investments | 122k | $333k | 14% | Mar 2026 |
|
| Persistent Asset Partners | 93k | $254k | 17% | Mar 2026 |
|
| Geode Capital Management | 93k | $253k | 25% | Mar 2026 |
|
| Renaissance Technologies | 90k | $233k | -6% | Dec 2025 |
|
| Vanguard Fiduciary Trust | 47k | $128k | 100% | Mar 2026 |
|
| Dimensional Fund Advisors | 44k | $119k | 23% | Mar 2026 |
|
| Citadel Advisors | 37k | $101k | 137% | Mar 2026 |
|
| XTX Topco | 26k | $67k | 100% | Dec 2025 |
|
| Bellevue Asset Management | 25k | $68k | 0% | Mar 2026 |
|
| BlackRock | 23k | $62k | 0% | Mar 2026 |
|
| Perritt Capital Management | 20k | $52k | 100% | Dec 2025 |
|
| Northern Trust | 19k | $50k | 100% | Dec 2025 |
|
| Acadian Asset Management | 10k | $27k | 0% | Mar 2026 |
|
| Daytona Street Capital | 10k | $27k | 100% | Mar 2026 |
|
| MAI Wealth Advisors | 3.6k | $9.8k | 0% | Mar 2026 |
|
| Tower Research Capital | 1.7k | $4.5k | -60% | Dec 2025 |
|
| UBS Group | 1.7k | $4.5k | -45% | Mar 2026 |
|
| Advisor Group Holdings | 460.00 | $1.2k | 1% | Dec 2025 |
|
| Wells Fargo & Company | 127.00 | $349.250000 | 0% | Mar 2026 |
|
| Morgan Stanley | 125.00 | $341.000000 | 0% | Mar 2026 |
|
| FNY Investment Advisers | 90.00 | $0 | -100% | Mar 2026 |
|
| Atlantic Trust | 83.00 | $215.999200 | 0% | Dec 2025 |
|
| Group One Trading | 37.00 | $100.998900 | 0% | Mar 2026 |
|
| Royal Bank of Canada | 36.00 | $0 | 100% | Mar 2026 |
|
| Bnp Paribas Arbitrage, Snc | 23.00 | $62.999300 | 0% | Mar 2026 |
|
| Goss Wealth Management | 21.00 | $57.000300 | 0% | Mar 2026 |
|
| SBI Securities | 11.00 | $30.000300 | 0% | Mar 2026 |
|
| Rockefeller Capital Management | 10.00 | $27.000000 | 100% | Mar 2026 |
|
| Caitong International Asset Management | 2.00 | $5.000000 | 100% | Mar 2026 |
|
| Vision Financial Markets | 2.00 | $6.000000 | 0% | Mar 2026 |
|
| Jones Financial Companies, L.L | 1.00 | $3.000000 | 0% | Dec 2025 |
|
| TSFG | 1.00 | $0 | 0% | Mar 2026 |
|
Who sold out of Aytu Biopharma?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Two Sigma Advisers | Dec 2025 | 43k | $111k |
| DRW Holdings | Dec 2025 | 29k | $76k |
| Sentinus | Dec 2025 | 20k | $52k |
| FMR | Sep 2025 | 5.00 | $9.000000 |
| Barclays | Sep 2025 | 1.00 | $2.000000 |